{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:02:15Z","timestamp":1788566535881,"version":"build-2803163510"},"reference-count":77,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2019,7,4]]},"DOI":"10.1080\/14737167.2019.1612242","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T10:02:51Z","timestamp":1557396171000},"page":"383-396","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":30,"title":["The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management"],"prefix":"10.1080","volume":"19","author":[{"given":"Yanina","family":"Jackson","sequence":"first","affiliation":[{"name":"Pfizer Inc, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Janssen","sequence":"additional","affiliation":[{"name":"ICON plc, Gaithersburg, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Fischer","sequence":"additional","affiliation":[{"name":"Parent Project Muscular Dystrophy, Hackensack, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Beaverson","sequence":"additional","affiliation":[{"name":"Pfizer Inc, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Loftus","sequence":"additional","affiliation":[{"name":"Pfizer Ltd, Tadworth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Betteridge","sequence":"additional","affiliation":[{"name":"Pfizer Ltd, Tadworth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Rhoten","sequence":"additional","affiliation":[{"name":"ICON plc, South San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emuella","family":"Flood","sequence":"additional","affiliation":[{"name":"ICON plc, Gaithersburg, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lundie","sequence":"additional","affiliation":[{"name":"Pfizer Canada Inc, Kirkland, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,5,9]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1080\/19466315.2015.1135820"},{"key":"CIT0002","unstructured":"Patient Centered Outcomes Research Institute About Us. [Cited 2018 Jul 30]. Available from: https:\/\/www.pcori.org\/about-us"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1111\/hex.12316"},{"key":"CIT0004","unstructured":"CMS initiatives to test shared decision making. Medscape medical news. [Cited 2018 Jul 24]. Available from: https:\/\/www.medscape.com\/viewarticle\/873198"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000273"},{"key":"CIT0006","unstructured":"H.R.34 \u2013 114th congress (2015\u20132016): 21st century cures act. [Cited 2018 Jul 24]. Available from: https:\/\/www.congress.gov\/bill\/114th-congress\/house-bill\/34\/"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30097-4"},{"key":"CIT0008","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation adn Research, Center for Biologics Evaluation and Research.\u00a0 [Cited 2019 May 1]. Patient-focused drug development: collecting comprehensive and representative input. Guidance for industry. Food and Drug Administration Staff, and Other Stakeholders. FDA Draft Guidance. 2018. Available from: https:\/\/www.fda.gov\/files\/drugs\/published\/Patient-Focused-Drug-Development-Collecting-Comprehensive-and-Representative-Input.pdf"},{"key":"CIT0009","unstructured":"Medical device innovation consortium (MDIC) patient centered benefit-risk project report: a framework for incorporating information on patient preferences regarding benefit and risk into regulatory assessments of new medical technology. [Cited 2018 Jul 24]. Available from: http:\/\/mdic.org\/wp-content\/uploads\/2015\/05\/MDIC_PCBR_Framework_Proof5_Web.pdf."},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0281-2"},{"key":"CIT0011","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation and Research [Cited 2019 May 1]. Patient preference information\u2013voluntary submission, review in premarket approval applications, humanitarian device exemption applications, andde novorequests, and inclusion in decision summaries and device labeling. Guidance for industry, food and drug administration staff, and other stakeholders. FDA Guidance; 2016. Available from: https:\/\/www.fda.gov\/media\/92593\/download"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.332"},{"key":"CIT0013","unstructured":"Institute for quality and efficiency in healthcare background: what are patient preferences? [Cited 2018 Jul 24]. Available from: https:\/\/www.iqwig.de\/en\/methods\/basic-principles\/background-what-are-patient-preferences.3757.html"},{"key":"CIT0014","unstructured":"Cancer research UK NICE given grant to research patient preference. [Cited 2018 Jul 24]. Available from: https:\/\/www.cancerresearchuk.org\/about-us\/cancer-news\/news-report\/2016-06-02-nice-given-grant-to-research-patient-preference"},{"key":"CIT0015","doi-asserted-by":"crossref","unstructured":"de Bekker-Grob EW, Berlin C, Levitan B, et al. Giving patients\u2019 preferences a voice in medical treatment life cycle: the PREFER public\u2013private project. Patient - Patient-Centered Outcomes Res. 2017 Jun;10(3):263-266.","DOI":"10.1007\/s40271-017-0222-3"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-013-0028-y"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-6419.2008.00552.x"},{"key":"CIT0018","volume-title":"A review of the discrete choice experiment-with emphasis on its application in healthcare","author":"Kjaer T","year":"2005"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-014-0084-x"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.08.2223"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-014-0170-x"},{"issue":"1","key":"CIT0022","first-page":"55","volume":"2","author":"Ryan M","year":"2003","journal-title":"Appl Health Econ Health Policy"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1586\/erp.10.29"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-016-0429-5"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-017-0253-9"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.38413"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_156686"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1177\/1077558712461283"},{"key":"CIT0029","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation and Research. [Cited 2019 May 1]. Use of real-world evidence to support regulatory decision making for medical devices. Guidance for industry and food and drug administration staff. FDA Guidance; 2017. Available from: https:\/\/www.fda.gov\/media\/99447\/download"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.442"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1186\/s12961-018-0337-6"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.04.011"},{"key":"CIT0033","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). [Cited 2019 May 1]. Duchenne muscular dystrophy and related dystrophinopathies: developing drugs for treatment. Guidance for industry. FDA Guidance; 2015. Available from: https:\/\/www.fda.gov\/media\/92233\/download"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.02.014"},{"key":"CIT0035","unstructured":"FDA weighs patients\u2019 risk tolerance in approving obesity device. [Cited 2018 Jul 25]. Available from: https:\/\/pink.pharmaintelligence.informa.com\/PS077790\/FDA-Weighs-Patients-Risk-Tolerance-in-Approving-Obesity-Device"},{"key":"CIT0036","unstructured":"Key considerations for developing & integrating patient perspectives in drug development: examination of the Duchenne case study. [Cited 2018 Jul 25]. Available from: https:\/\/www.bio.org\/sites\/default\/files\/BIO_PPMD_Paper_2016.pdf"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1456414"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1440199"},{"key":"CIT0039","unstructured":"Bringing the patient voice into drug development. [Cited 2018 Dec 12]. Available from: https:\/\/www.lls.org\/blog\/message-to-the-fda-incorporate-patient-voice-into-drug-development"},{"key":"CIT0040","author":"Paquin R","journal-title":"Orphanet"},{"key":"CIT0041","author":"Peay H","journal-title":"Value Health"},{"issue":"9","key":"CIT0042","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s11136-018-1891-7","volume":"27","author":"Hollin IL","year":"2018","journal-title":"Qual Life Res"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00275.x"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-010-9621-9"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.08.1781"},{"key":"CIT0046","unstructured":"Patient-centered clinical trial design workshop. From p-values to patient values: MDIC to reveal patient-generated p-values from Parkinson\u2019s patient preference study. [Cited 2018 May 18]. Available from: http:\/\/mdic.org\/spi\/pcor\/workshop\/"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.09.830"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2009.02696.x"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.01.054"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-013-0028-y"},{"key":"CIT0051","unstructured":"Testing preference elicitation methods in clinical case studies. [Cited 2018 Jul 30]. Available from: https:\/\/www.imi-prefer.eu\/about\/studies\/"},{"key":"CIT0052","unstructured":"A lifecycle approach to FDA\u2019s structured benefit-risk assessment framework. [Cited 2018 Dec 12]. Available from: https:\/\/www.bio.org\/sites\/default\/files\/files\/FDA_STBRA_WP.pdf"},{"key":"CIT0053","unstructured":"FDA patient-focused drug development guidance series for enhancing the incorporation of the patient\u2019s voice in medical product development and regulatory decision making. [Cited 2018 Dec 12]. Available from: https:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/ucm610279.htm."},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-014-4044-2"},{"key":"CIT0055","unstructured":"European medicines agency benefit-risk methodology project. [Cited 2018 Dec 12]. Available from: https:\/\/www.ema.europa.eu\/documents\/report\/benefit-risk-methodology-project_en.pdf"},{"key":"CIT0056","unstructured":"European medicines agency guidance document on the content of the rapporteur day critical assessment report. [Cited 2018 Dec 12]. Available from: https:\/\/www.ema.europa.eu\/documents\/regulatory-procedural-guideline\/d80-assessment-report-overview-guidance-rev1017_en.pdf"},{"key":"CIT0057","unstructured":"European medicines agency benefit-risk methodology project update on work package 5: effects table pilot (Phase I). [Cited 2018 Dec 12] Available from: https:\/\/www.ema.europa.eu\/documents\/report\/benefit-risk-methodology-project-update-work-package-5-effects-table-pilot-phase-i_en.pdf"},{"key":"CIT0058","unstructured":"European medicines agency shaping regulatory science to 2025. [Cited 2018 Dec 12]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/shaping-regulatory-science-2025"},{"issue":"4","key":"CIT0059","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/annonc\/mdw685","volume":"28","author":"Rummel M","year":"2016","journal-title":"Ann Oncol"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-4068-9"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1186\/s40900-016-0052-9"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-016-0763-8"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.12.015"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-018-0305-9"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-017-0544-y"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2016.07.043"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12938"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S152870"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-5-201203060-00010"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.2100"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-017-0835-5"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-018-00933-9"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2010.11.013"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.04.004"},{"key":"CIT0075","unstructured":"FDA Voice. How patient preferences contribute to regulatory decisions for medical devices. [Cited 2018 Jul 25]. Available from: https:\/\/blogs.fda.gov\/fdavoice\/index.php\/tag\/patient-preference-initiative\/"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1177\/2325967117695788"},{"issue":"7","key":"CIT0077","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/acr.21657","volume":"64","author":"Fraenkel L","year":"2012","journal-title":"Arthritis Care Res"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2019.1612242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T20:20:34Z","timestamp":1721247634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2019.1612242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,9]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7,4]]}},"alternative-id":["10.1080\/14737167.2019.1612242"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2019.1612242","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-12-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}